West Pharmaceutical Services | WST - Operating Profit

Stock Price
306.16
Daily Change
-3.54 -1.14%
Monthly
23.94%
Yearly
42.70%
Q2 Forecast
299.61

West Pharmaceutical Services reported $177.1M in Operating Profit for its fiscal quarter ending in March of 2026.





Operating Profit Change Date
Align Technology USD 224.71M 40.06M Dec/2025
Avanos Medical USD 24.77M 5.8M Dec/2025
Baxter International USD -214.2M 415.4M Dec/2025
Becton, Dickinson and Co. USD 663M 163M Dec/2025
Cerus USD -1.45M 488K Dec/2024
Charles River Laboratories USD 75.82M 57.98M Dec/2025
Cooper Companies USD 212.8M 72.4M Dec/2025
Dentsply International USD 538M 26M Dec/2025
Haemonetics USD 67.4M 8.9M Dec/2025
ICU Medical USD 26.09M 770K Dec/2025
Insulet USD 146.3M 28.6M Dec/2025
Integra LifeSciences USD 66M 54.24M Dec/2025
IQVIA Holdings USD 2.68B 2.1B Dec/2025
J&J USD 6.62B 1.03B Mar/2026
Medtronic USD 1.74B 40M Dec/2025
Merit Medical Systems USD 54.2M 11.58M Dec/2025
Neogen USD -3.3M 2.08M Dec/2025
OraSure Technologies USD -13.59M 2.13M Dec/2025
Quidel USD -37.3M 667.5M Dec/2025
Repligen USD 19.97M 7.29M Dec/2025
Rockwell Medical USD 515K 1.84M Jun/2024
Solventum Corp USD 105M 1.58B Dec/2025
STAAR Surgical USD -10.93M 29.42M Dec/2025
Terumo JPY 43.88B 1.21B Dec/2025
Utah Medical Products USD 2.44M 1.32M Dec/2025
West Pharmaceutical Services USD 177.1M 14.6M Mar/2026